Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

BACKGROUND Elderly individuals with chronic kidney disease (CKD) have high rates of comorbid conditions, including cardiovascular disease and its risk factors, and CKD-related complications. In individuals aged > or = 65 years, we sought to describe the prevalence of CKD determined from laboratory test results in the Kidney Early Evaluation Program (KEEP; n = 27,017) and National Health and Nutrition Examination Survey (NHANES) 1999-2006 (n = 5,538) and the prevalence of diagnosed CKD determined from billing codes in the Medicare 5% sample (n = 1,236,946). In all 3 data sources, we also explored comorbid conditions and CKD-related complications. METHODS CKD was identified as decreased estimated glomerular filtration rate (<60 mL/min/1.73 m(2)) or increased albumin-creatinine ratio in KEEP and NHANES; CKD was identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes in Medicare. Investigated comorbid conditions included diabetes, hypertension, high cholesterol level, coronary artery disease, congestive heart failure, cerebrovascular disease, peripheral vascular disease, and cancer, and CKD-related complications included anemia, hypocalcemia, hyperphosphatemia, and hyperparathyroidism. RESULTS The prevalence of CKD was approximately 44% in both KEEP and NHANES participants, and the prevalence of diagnosed CKD was 7% in Medicare beneficiaries. In all 3 data sets, the prevalence of CKD or diagnosed CKD was higher in participants aged > or = 80 years and those with comorbid conditions. For KEEP and NHANES participants, the prevalence of most comorbid conditions and CKD complications increased with decreasing estimated glomerular filtration rate. For participants with CKD stages 3-5, a total of 29.2% (95% CI, 27.8-30.6) in KEEP and 19.9% (95% CI, 17.0-23.1) in NHANES had anemia, 0.7% (95% CI, 0.4-0.9) and 0.6% (95% CI, 0.3-1.3) had hypocalcemia, 5.4% (95% CI, 4.7-6.1) and 6.4% (95% CI, 5.1-8.0) had hyperphosphatemia, and 52.0% (95% CI, 50.4-53.6) and 30.0% (95% CI, 25.9-34.3) had hyperparathyroidism, respectively. CONCLUSIONS CKD is common in the elderly population and is associated with high frequencies of concomitant comorbid conditions and biochemical abnormalities. Because CKD is not commonly diagnosed, greater emphasis on physician education may be beneficial.

[1]  Carl van Walraven,et al.  When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. , 2009, Kidney international.

[2]  Kosha Bramesfeld,et al.  Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[3]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[4]  R. Glassock Estimated glomerular filtration rate: time for a performance review? , 2009, Kidney international.

[5]  T. Hostetter,et al.  eGFR: is it ready for early identification of CKD? , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[6]  C. Winearls,et al.  Screening for CKD with eGFR: doubts and dangers. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[7]  V. Bellizzi,et al.  [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[8]  L. Stevens,et al.  Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  C. Jurkovitz,et al.  The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  J. Coresh,et al.  CKD in the elderly--old questions and new challenges: World Kidney Day 2008. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Luxia Zhang,et al.  Prevalence and factors associated with CKD: a population study from Beijing. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  J. Coresh,et al.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  K. Abbott,et al.  Association of oral sodium phosphate purgative use with acute kidney injury. , 2007, Journal of the American Society of Nephrology : JASN.

[14]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[15]  C. Schmid,et al.  Evaluation of the modification of diet in renal disease study equation in a large diverse population. , 2007, Journal of the American Society of Nephrology : JASN.

[16]  T. Grobner,et al.  Gadolinium and nephrogenic systemic fibrosis. , 2007, Kidney international.

[17]  C. Winearls,et al.  An epidemic of chronic kidney disease: fact or fiction? , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  Saunak Sen,et al.  Polypharmacy and Prescribing Quality in Older People , 2006, Journal of the American Geriatrics Society.

[19]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[20]  E. Vittinghoff,et al.  Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. , 2006, Journal of vascular surgery.

[21]  L. Fried,et al.  Cystatin-C and inflammatory markers in the ambulatory elderly. , 2005, The American journal of medicine.

[22]  Katrin Uhlig,et al.  Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[23]  L. Stevens,et al.  Chronic kidney disease in the elderly--how to assess risk. , 2005, The New England journal of medicine.

[24]  D. Siscovick,et al.  Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.

[25]  L. Fried,et al.  Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults , 2005, Annals of Internal Medicine.

[26]  B. Psaty,et al.  Cystatin-C and mortality in elderly persons with heart failure. , 2005, Journal of the American College of Cardiology.

[27]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[28]  C. Gullion,et al.  Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.

[29]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[30]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[31]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[32]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[33]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[34]  B. Kasiske Relationship between vascular disease and age-associated changes in the human kidney. , 1987, Kidney international.

[35]  B. Brenner,et al.  Effects of aging on the renal glomerulus. , 1986, The American journal of medicine.

[36]  S. Adler,et al.  Cardiovascular Implications of Chronic Kidney Disease in Older Adults , 2008, Drugs & aging.

[37]  Keith C. Norris,et al.  High Prevalence of Stage 3 Chronic Kidney Disease in Older Adults Despite Normal Serum Creatinine , 2008, Journal of General Internal Medicine.

[38]  Benjamin J. Epstein,et al.  Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure , 2007 .